Lytica Therapeutics
Lip Nam L. is an accomplished scientist in the field of biology and microbiology with extensive experience in designing and optimizing cellular and microbiological assays. Currently serving as an Associate Principal Scientist at Lytica Therapeutics since January 2020, Lip Nam L. focuses on antibody-drug conjugates (ADCs) and has previously held significant roles, including Senior Scientist at Lytica and Research Fellow at Albert Einstein College of Medicine. Academic qualifications include a PhD in Microbiology from the London School of Hygiene and Tropical Medicine, complemented by a Master’s in Molecular Biology of Infectious Diseases from the same institution and a Bachelor's Degree in Biomedical Sciences from Universiti Putra Malaysia. A strong background in research includes significant contributions to understanding bacterial infection mechanisms and leading microbiological teams and projects.
This person is not in any teams
This person is not in any offices
Lytica Therapeutics
1 followers
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.